Mounjaro Growth Plan Targets Over R2 Billion in South Africa by June 2027
Eli Lilly’s Mounjaro push in Africa starts with a distributor target for South Africa sales exceeding 2 billion rand in the year ending June 2027. The country’s GLP-1 market nearly doubled to 2.8 billion rand, while Mounjaro’s share rose from 15% to 53%. Pending registrations in Kenya and Nigeria could expand demand further.